Previous Page  19 / 28 Next Page
Information
Show Menu
Previous Page 19 / 28 Next Page
Page Background

Pathology 2018

Research & Reviews: Journal of Medical and Health Sciences

ISSN: 2319-9865

Page 74

October 08-09, 2018

Edinburgh, Scotland

17

th

International Conference on

Pathology & Cancer

Epidemiology

T

hrombotic thrombocytopenic purpura (TTP) is one of

the most serious and life-threatening form of thrombotic

microangiopathy characterized by microangiopathic hemolytic

anemia, severe thrombocytopenia, and multiple organs damage

due to VWF–platelet aggregations in the arterioles and capillaries

of end organs. The thrombi are found most extensively in the

heart, brain, kidney, pancreas, spleen, mesentery and adrenal

glands. Thrombocytopenia results from consumption of platelets

in the thrombotic process, while erythrocyte fragmentation and

hemolysis result from mechanical injury induced by abnormally

high shear stress in the microvasculature. Pathophysiology

involves the absence of von Willebrand factor cleaving enzyme

(ADAMTS-13), resulting in unusually large von Willebrand

multimers. These multimers lead to platelet aggregations,

microthrombi and subsequent thrombocytopenia. About 35% of

adult patients have idiopathic (acquired) TTP due to formation

of antibodies/inhibitors against ADAMTS13 (a disintegrin and

metalloprotease with thrombospondin type 1 repeats, member

13). These patients develop severe ADAMTS13 deficiency and

acute TTP. The inhibitors are primarily IgG but less often IgM.

The plasma ADAMTS13 activity level is less than 10% or 5% in

acute TTP. Inherited form of TTP is also described in children

due to mutations of ADAMTS13 gene located on the long arm of

chromosome 9 An ADAMTS13 level >10% excludes the diagnosis

of TTP. Early diagnosis of TTP is essential to initiate appropriate

treatment. The first-line therapy for acute TTP is based on daily

therapeutic plasma exchange supplying deficient ADAMTS13.

Immune modulators are humanized anti-CD20 monoclonal

antibody rituximab.

qaiserhasnain123@yahoo.com

Thrombotic thrombocytopenic purpura and the role of

ADAMTS13 as a key enzyme in the pathogenesis of TTP

Qaiser Hasnain

Amna Inayat Medical College - University of Health Sciences, Pakistan

RRJMHS 2018

Volume: 7